Samsung Life Announces New USD 30NC5 Tier 2 Subordinated Bond at an IPG of 7.00%

Korea’s largest life insurer makes its USD debut with a 30NC5 Tier 2 bond at 7.00% – we view it as attractively priced.

iFAST Research Team
iFAST Research Team26 Oct 2026 65 Views
Samsung Life Announces New USD 30NC5 Tier 2 Subordinated Bond at an IPG of 7.00%

  • Samsung Life Insurance Co., Ltd. ("Samsung Life") is South Korea's largest life insurer and a core affiliate of the Samsung Group. The insurer is launching a new USD benchmark-sized 30-year non-call 5-year (30NC5) Tier 2 Subordinated Capital Securities, its first-ever bond issuance, under a board-approved plan to raise up to US$1.5 billion in offshore hybrid capital – which would be the largest such offering by a Korean insurer. Settlement is slated for 2 November 2026, with the first call date on 2 November 2031, and Initial Price Guidance (IPG) has been set at 7.00%.
  • The expected issue ratings of A2 (Moody's) / A+ (Fitch) come in two notches below the Issuer's own ratings of Aa3 / AA. This notching reflects the deeply subordinated ranking of these securities, which sit behind all other senior and subordinated creditors, including policyholders and dated subordinated creditors, and only rank ahead of shareholders.
  • Consolidated net profit rose 35.8% year-on-year (YoY) to KRW1.9 trillion in 1H2026, ended 30 June 2026, driven by investment profit of KRW1.9 trillion, which was boosted by dividends and income from subsidiaries. Insurance service profit, however, fell 35.9% YoY to KRW533.1 billion, as higher medical claims and a one-off KRW83.0 billion provision for wages and retirement benefits weighed on underwriting results. New business contractual service margin (CSM), a key indicator of future insurance profits, grew 20.4% YoY to KRW1.7 trillion on the back of strong sales of protection-type products such as whole life insurance.
  • Momentum slowed in 2Q2026, with net profit for the quarter down 9.1% YoY to KRW689.9 billion on weaker insurance income. The quarter also included one-off CSM adjustments made in line with the Financial Supervisory Service's guidelines, reflecting more conservative actuarial assumptions on new rider loss ratios and expense ratios. On a brighter note, Samsung Life's exclusive agent channel grew by about 2,100 agents year-to-date to close to 45,000 as at end-June 2026, supporting future new business growth.
  • Samsung Life’s Korean Insurance Capital Standard (K-ICS) solvency ratio stood at a solid 208% as at end-June 2026, with available capital of KRW129.6 trillion covering required capital of KRW62.2 trillion more than twice over, while its basic capital (Tier 1) K-ICS ratio remained stable at 177% – among the highest in the Korean insurance sector. Samsung Life also holds about 8.5% of Samsung Electronics' common shares, providing a large and growing stream of dividend income that adds to its financial flexibility as it pursues overseas investments, including a reported ~15% stake in US-listed Principal Financial Group.
  • Samsung Life's 7.00% IPG offers a pickup of about 205bps over US Treasuries of a similar tenor to its 2031 first call, meaning investors are paid roughly two percentage points a year above a Treasury for taking on Samsung Life's subordinated credit risk. As the coupon resets to the 5-year Treasury plus the initial spread in 2031, this spread, set at pricing, is also what investors would lock in beyond the first call should the bond not be redeemed.
  • Compared to similar USD subordinated bonds from global life insurers, Samsung Life's IPG provides a pickup of about 53 bps over HLINSU 6.300% 24Jun2055 Corp (USD), which trades at 6.47% (173bps over Treasuries) with 3.7 years to call, despite Samsung Life's stronger A2/A+ issue ratings versus Hanwha Life's A3/A-. ANGINC 7.000% 01Dec2055 Corp (USD) offers a higher 8.47% (352bps over Treasuries) with 4.1 years to call, about 147bps above Samsung Life, but this premium reflects its sub-investment grade BB+/BB+ ratings and lower ranking, as the bond is ranked junior subordinated.
  • Therefore, we view the Samsung Life new issue as attractively priced at the IPG of 7.00%. Investors should note that this is the initial price guidance, which is subject to change when the final price guidance (FPG) is set, and pricing could tighten if demand is strong. Investors should also stay mindful of the risks that come with the structure – the securities rank behind policyholders and all other creditors, coupons can be cancelled on a non-cumulative basis, and the bond may not be called in 2031.

Table 1: Peer Comparison

Issuer

Issue

Bond Rank

Credit Rating

(S&P / Moody’s / Fitch)

Ask Price

Call Date / Maturity Date

(Years to Call / Maturity)

Yield to Call
(%)

Samsung Life Insurance

SSLINS 7.000% 02Nov2056 Corp (USD)

Subordinated

- / A2 / A+ *

100

02Nov2031 / 02Nov2056

(5.0 / 30.0)

7.00 **

American National Group

ANGINC 7.000% 01Dec2055 Corp (USD)

Jr Subordinated

BB+ / - / BB+

94.21

01Dec2030 / 01Dec2055

(4.1 / 29.1)

8.47

Hanwha Life Insurance

HLINSU 6.300% 24Jun2055 Corp (USD)

Subordinated

- / A3 / A-

99.44

24Jun2030 / 24Jun2055

(3.7 / 28.7)

6.47

Data as of 26 October 2026

Source: Bloomberg

*Expected Credit Rating

** Yield is based on IPG

Declaration: For specific disclosure, at the time of publication of this report, IFPL (via its connected and associated entities) holds NIL positions. The analyst who produced this report hold NIL positions in the abovementioned securities. This research report was prepared with the assistance of artificial intelligence (AI) tools. iFAST Financial Pte Ltd does not rely exclusively on AI for content generation; the content of this report – including all investment theses, ratings, price targets and conclusions – has been independently reviewed and verified by the research analyst(s) to ensure accuracy and professional integrity.

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://fsm.global/sg/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.